Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Tobacco Use 1 Tobacco Smoking 1 Testicular Neoplasms 1 Neoplasms 1 Lymphoma, Large B-Cell, Diffuse 1 Health Behavior 1 Colorectal Neoplasms 1 Breast Neoplasms 1

Interventions

Fluorouracil 255 Leucovorin 224 Oxaliplatin 218 Irinotecan 206 Bevacizumab 200 Capecitabine 144 Cetuximab 136 Panitumumab 68 Folfox protocol 63 regorafenib 50 Colonoscopy 44 pembrolizumab 42 IFL protocol 39 Radiotherapy 32 Nivolumab 31 Drug Therapy 27 trifluridine tipiracil drug combination 26 Gemcitabine 24 Blood Specimen Collection 23 Chemotherapy, Adjuvant 20 Surveys and Questionnaires 19 Celecoxib 19 Surgical Procedures, Operative 16 durvalumab 15 Neoadjuvant Therapy 15 Cyclophosphamide 14 Cisplatin 14 aflibercept 13 Standard of Care 13 Pemetrexed 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Colorectal Neoplasms × Costs and Cost Analysis × Clear all

NCT02037646 2017-10-27

FIT

University of Malaya

Phase NA Completed

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡